Brian D Blakey

US Patent:

20200000870, Jan 2, 2020

Filed:

Feb 8, 2019

Appl. No.:

16/271185

Inventors:

- Monaco, MC
Mark Bamberger - South Glastonbury CT, US
Brian Blakey - Doylestown PA, US

International Classification:

A61K 38/07
A61K 45/06
A61K 31/22
A61K 31/366
A61K 31/40
A61K 31/404
A61K 31/505
A61P 9/10
A61K 31/215
A61K 31/351

Abstract:

Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

US Patent:

20180344797, Dec 6, 2018

Filed:

Dec 20, 2017

Appl. No.:

15/848198

Inventors:

- Monaco, MC
Mark Bamberger - South Glastonbury CT, US
Brian Blakey - Doylestown PA, US

International Classification:

A61K 38/07
A61P 9/10
A61K 31/215
A61K 31/351
A61K 45/06
A61K 31/22
A61K 31/366
A61K 31/40
A61K 31/404
A61K 31/505

Abstract:

Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

US Patent:

20180339012, Nov 29, 2018

Filed:

Dec 20, 2017

Appl. No.:

15/848712

Inventors:

- Monaco, MC
Mark Bamberger - South Glastonbury CT, US
Brian Blakey - Doylestown PA, US
Marc W. Andersen - Raleigh NC, US

International Classification:

A61K 38/07
A61P 9/10
A61K 31/215
A61K 31/351
A61K 45/06
A61K 31/22
A61K 31/366
A61K 31/40
A61K 31/404
A61K 31/505

Abstract:

Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.

US Patent:

20150283200, Oct 8, 2015

Filed:

Jul 31, 2013

Appl. No.:

14/418809

Inventors:

- Monaco, MC
Mark Bamberger - South Glastonbury CT, US
Brian Blakey - Doylestown PA, US

International Classification:

A61K 38/07
A61K 31/505
A61K 45/06
A61K 31/40

Abstract:

Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

US Patent:

20150157685, Jun 11, 2015

Filed:

Jul 31, 2013

Appl. No.:

14/418827

Inventors:

- Monaco, MC
Mark Bamberger - South Glastonbury CT, US
Brian Blakey - Doylestown PA, US
Marc W. Andersen - Raleigh NC, US

Assignee:

Stealth Peptides International, Inc. - Monaco

International Classification:

A61K 38/07
A61K 31/40
A61K 31/505
A61K 31/351
A61K 31/215
A61K 45/06
A61K 31/404

Abstract:

Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.